Rob Johnston made a real difference in his lifetime – and his story is well worth telling.

Nerf guns are fun. But not when they cause ocular trauma.

There's chronic, and then there's chronic DME – and treatment outcomes differ accordingly.

The IBM PC changed computing forever. What might be ophthalmology's equivalent?

How three leading lights and one CEO are tackling corneal disease through pioneering research and development.

This month’s approvals, acquisitions, revenue reports, regulatory action and trial results.

Protocol I subanalysis suggests that earlier treatment of DME eyes with persistent edema maximizes visual benefit.

It takes work. But it's more than worth it, when done intelligently.

Mining the last five years of the retinal detachment literature.

Acquisitions, funding rounds, approvals and IP this month